Cencora, Inc. $COR Shares Sold by Principal Financial Group Inc.

Principal Financial Group Inc. reduced its stake in shares of Cencora, Inc. (NYSE:COR) by 4.5% during the 3rd quarter, HoldingsChannel reports. The fund owned 248,162 shares of the company’s stock after selling 11,618 shares during the period. Principal Financial Group Inc.’s holdings in Cencora were worth $77,558,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the business. Norges Bank acquired a new stake in shares of Cencora in the second quarter valued at about $695,215,000. Mizuho Markets Americas LLC grew its stake in Cencora by 116.4% during the 3rd quarter. Mizuho Markets Americas LLC now owns 212,800 shares of the company’s stock worth $66,506,000 after buying an additional 1,511,906 shares during the last quarter. Artisan Partners Limited Partnership acquired a new position in Cencora during the 2nd quarter valued at about $411,888,000. Vanguard Group Inc. raised its stake in shares of Cencora by 5.3% during the second quarter. Vanguard Group Inc. now owns 22,479,041 shares of the company’s stock valued at $6,740,340,000 after purchasing an additional 1,125,661 shares in the last quarter. Finally, Viking Global Investors LP boosted its stake in Cencora by 95.0% during the 2nd quarter. Viking Global Investors LP now owns 2,081,732 shares of the company’s stock valued at $624,207,000 after purchasing an additional 1,013,913 shares in the last quarter. 97.52% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Cencora

In other Cencora news, EVP Silvana Battaglia sold 1,677 shares of the company’s stock in a transaction on Friday, December 19th. The stock was sold at an average price of $345.00, for a total value of $578,565.00. Following the transaction, the executive vice president directly owned 18,796 shares of the company’s stock, valued at $6,484,620. This represents a 8.19% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, EVP Elizabeth S. Campbell sold 3,351 shares of the stock in a transaction on Friday, December 19th. The stock was sold at an average price of $342.10, for a total value of $1,146,377.10. Following the sale, the executive vice president directly owned 23,891 shares in the company, valued at approximately $8,173,111.10. This trade represents a 12.30% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 20,316 shares of company stock worth $7,151,265. 0.38% of the stock is owned by insiders.

Cencora Stock Down 0.4%

Shares of NYSE COR opened at $362.23 on Wednesday. Cencora, Inc. has a 1 year low of $237.71 and a 1 year high of $377.54. The firm’s 50-day moving average is $347.21 and its 200-day moving average is $325.24. The company has a current ratio of 0.90, a quick ratio of 0.55 and a debt-to-equity ratio of 4.32. The firm has a market capitalization of $70.27 billion, a PE ratio of 45.56, a price-to-earnings-growth ratio of 1.73 and a beta of 0.68.

Cencora (NYSE:COR) last released its quarterly earnings data on Wednesday, November 5th. The company reported $3.84 earnings per share for the quarter, beating the consensus estimate of $3.79 by $0.05. Cencora had a return on equity of 227.15% and a net margin of 0.48%.The business had revenue of $83.73 billion for the quarter, compared to analysts’ expectations of $83.36 billion. During the same quarter in the previous year, the business posted $3.34 EPS. Cencora’s revenue for the quarter was up 5.9% on a year-over-year basis. Equities analysts expect that Cencora, Inc. will post 15.37 EPS for the current year.

Wall Street Analyst Weigh In

COR has been the subject of a number of analyst reports. Robert W. Baird set a $415.00 price objective on shares of Cencora in a research note on Tuesday, January 13th. TD Cowen upped their target price on Cencora from $350.00 to $400.00 and gave the stock a “buy” rating in a research report on Monday, November 10th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Cencora in a research note on Monday, December 29th. Wells Fargo & Company boosted their target price on shares of Cencora from $354.00 to $405.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 11th. Finally, Mizuho boosted their price target on Cencora from $340.00 to $380.00 and gave the company an “outperform” rating in a research note on Thursday, November 6th. One analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, Cencora currently has an average rating of “Moderate Buy” and a consensus target price of $393.08.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.